{"id":"https://openalex.org/W3103380324","doi":"https://doi.org/10.1136/jitc-2020-sitc2020.0526","title":"526 InhibigenTM-specific responses suppress anti-tumor immunity and promote tumor growth","display_name":"526 InhibigenTM-specific responses suppress anti-tumor immunity and promote tumor growth","publication_year":2020,"publication_date":"2020-11-01","ids":{"openalex":"https://openalex.org/W3103380324","doi":"https://doi.org/10.1136/jitc-2020-sitc2020.0526","mag":"3103380324"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2020-sitc2020.0526","doi":"https://doi.org/10.1136/jitc-2020-sitc2020.0526","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2020-sitc2020.0526","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and young investigator award abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1136/jitc-2020-sitc2020.0526","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036783909","display_name":"Victoria L. DeVault","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118551","display_name":"Genocea (United States)","ror":"https://ror.org/0296rp189","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118551"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victoria DeVault","raw_affiliation_strings":["Genocea Biosciences, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genocea Biosciences, Cambridge, USA","institution_ids":["https://openalex.org/I4210118551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002478532","display_name":"Tulin Dadali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118551","display_name":"Genocea (United States)","ror":"https://ror.org/0296rp189","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118551"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tulin Dadali","raw_affiliation_strings":["Genocea Biosciences, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genocea Biosciences, Cambridge, USA","institution_ids":["https://openalex.org/I4210118551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077557341","display_name":"Hanna Starobinets","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118551","display_name":"Genocea (United States)","ror":"https://ror.org/0296rp189","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118551"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hanna Starobinets","raw_affiliation_strings":["Genocea Biosciences, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genocea Biosciences, Cambridge, USA","institution_ids":["https://openalex.org/I4210118551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069648611","display_name":"Kevin Lema","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118551","display_name":"Genocea (United States)","ror":"https://ror.org/0296rp189","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118551"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Lema","raw_affiliation_strings":["Genocea Biosciences, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genocea Biosciences, Cambridge, USA","institution_ids":["https://openalex.org/I4210118551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026569672","display_name":"Stephanie Rinaldi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118551","display_name":"Genocea (United States)","ror":"https://ror.org/0296rp189","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118551"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie Rinaldi","raw_affiliation_strings":["Genocea Biosciences, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genocea Biosciences, Cambridge, USA","institution_ids":["https://openalex.org/I4210118551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016380391","display_name":"Osaruese Odeh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118551","display_name":"Genocea (United States)","ror":"https://ror.org/0296rp189","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118551"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Osaruese Odeh","raw_affiliation_strings":["Genocea Biosciences, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genocea Biosciences, Cambridge, USA","institution_ids":["https://openalex.org/I4210118551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032019897","display_name":"Julie Arnold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118551","display_name":"Genocea (United States)","ror":"https://ror.org/0296rp189","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118551"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Arnold","raw_affiliation_strings":["Genocea Biosciences, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genocea Biosciences, Cambridge, USA","institution_ids":["https://openalex.org/I4210118551"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Dylan Sheehan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118551","display_name":"Genocea (United States)","ror":"https://ror.org/0296rp189","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118551"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dylan Sheehan","raw_affiliation_strings":["Genocea Biosciences, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genocea Biosciences, Cambridge, USA","institution_ids":["https://openalex.org/I4210118551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072318387","display_name":"Cindy H. Nguyen","orcid":"https://orcid.org/0000-0002-0079-0669","observed_orcids":["https://orcid.org/0000-0002-0079-0669"]},"institutions":[{"id":"https://openalex.org/I4210118551","display_name":"Genocea (United States)","ror":"https://ror.org/0296rp189","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118551"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cindy Nguyen","raw_affiliation_strings":["Genocea Biosciences, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genocea Biosciences, Cambridge, USA","institution_ids":["https://openalex.org/I4210118551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020122874","display_name":"Louisa M. Dowal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118551","display_name":"Genocea (United States)","ror":"https://ror.org/0296rp189","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118551"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louisa Dowal","raw_affiliation_strings":["Genocea Biosciences, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genocea Biosciences, Cambridge, USA","institution_ids":["https://openalex.org/I4210118551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044116416","display_name":"Jessica Baker Flechtner","orcid":"https://orcid.org/0000-0002-7034-7689","observed_orcids":["https://orcid.org/0000-0002-7034-7689"]},"institutions":[{"id":"https://openalex.org/I4210118551","display_name":"Genocea (United States)","ror":"https://ror.org/0296rp189","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118551"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Flechtner","raw_affiliation_strings":["Genocea Biosciences, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genocea Biosciences, Cambridge, USA","institution_ids":["https://openalex.org/I4210118551"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029038858","display_name":"Alberto Visintin","orcid":"https://orcid.org/0000-0002-2869-5049","observed_orcids":["https://orcid.org/0000-0002-2869-5049"]},"institutions":[{"id":"https://openalex.org/I4210118551","display_name":"Genocea (United States)","ror":"https://ror.org/0296rp189","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118551"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alberto Visintin","raw_affiliation_strings":["Genocea Biosciences, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genocea Biosciences, Cambridge, USA","institution_ids":["https://openalex.org/I4210118551"]}]},{"author_position":"last","author":{"id":null,"display_name":"Hubert Lam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118551","display_name":"Genocea (United States)","ror":"https://ror.org/0296rp189","country_code":"US","type":"company","lineage":["https://openalex.org/I4210118551"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hubert Lam","raw_affiliation_strings":["Genocea Biosciences, Cambridge, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genocea Biosciences, Cambridge, USA","institution_ids":["https://openalex.org/I4210118551"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210118551"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A322.1","last_page":"A322"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8695999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8695999979972839,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.12960000336170197,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/personalized-cancer-vaccines","display_name":"personalized cancer vaccines","score":0.746999979019165},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.6549999713897705},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.7099999785423279},{"id":"https://openalex.org/keywords/b16f10-melanoma","display_name":"B16F10 melanoma","score":0.8500000238418579},{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.6349999904632568},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8429999947547913},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.6930000185966492},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.7170000076293945},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.42800000309944153},{"id":"https://openalex.org/keywords/t-cell-cytokine-secretion","display_name":"T cell cytokine secretion","score":0.6779999732971191},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.42500001192092896},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.4309999942779541},{"id":"https://openalex.org/keywords/cd4-t-cells","display_name":"CD4+ T cells","score":0.4740000069141388}],"concepts":[{"id":"https://openalex.org/C2779341262","wikidata":"https://www.wikidata.org/wiki/Q182581","display_name":"Immunity","level":3,"score":0.6371946334838867},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4954167604446411},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.42224544286727905},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3657240867614746},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.306465208530426},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2819090187549591},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26674044132232666}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2020-sitc2020.0526","doi":"https://doi.org/10.1136/jitc-2020-sitc2020.0526","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2020-sitc2020.0526","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and young investigator award abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2020-sitc2020.0526","doi":"https://doi.org/10.1136/jitc-2020-sitc2020.0526","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2020-sitc2020.0526","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and young investigator award abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2781772206"],"related_works":["https://openalex.org/W3213336453","https://openalex.org/W3180249681","https://openalex.org/W4313374455","https://openalex.org/W4319433671","https://openalex.org/W4282939437","https://openalex.org/W3083492270","https://openalex.org/W3029314960","https://openalex.org/W2978246184","https://openalex.org/W3123426619","https://openalex.org/W2947123000"],"abstract_inverted_index":{"Background":[0],"Personalized":[1],"cancer":[2,331,353,447],"immunotherapies":[3,448],"can":[4,45,97],"generate":[5],"potent":[6],"antitumor":[7],"responses":[8,131,197,239],"yet":[9],"finding":[10],"the":[11,75,143,176,208,296,334,350,387,390,408,415,423],"right":[12],"targets":[13],"remains":[14],"challenging.":[15],"The":[16,323],"ATLASTM":[17],"platform":[18,392],"employs":[19],"ex":[20],"vivo":[21],"functional":[22,209],"screening":[23],"of":[24,40,77,86,155,211,224,249,269,281,292,327,352,389,414],"tumor":[25,71,100,126,199,279,297,314,370],"mutations":[26,160],"using":[27,134],"autologous":[28],"cells":[29,285],"to":[30,63,240,263,277],"identify":[31],"patient-specific":[32],"neoantigens.":[33],"Stimulatory":[34],"neoantigens":[35,58],"are":[36,260],"identified":[37],"by":[38,428],"upregulation":[39],"inflammatory":[41],"cytokine":[42,64,252],"secretion":[43],"and":[44,66,73,90,104,138,198,233,286,333,347,395,419,425,433],"be":[46,345],"employed":[47],"in":[48,67,88,121,153,175,214,226,295,329,338,349,356,405,420,454],"vaccines":[49,118],"or":[50,115,201,298,364,380],"cell":[51,188,238,251],"therapies.":[52],"Conversely,":[53],"ATLAS":[54,106,391],"also":[55],"identifies":[56],"inhibitory":[57],"(termed":[59],"Inhibigens)":[60],"that":[61,257,341,373],"lead":[62],"downregulation,":[65],"murine":[68],"models":[69],"accelerate":[70],"growth":[72,315,371],"abrogate":[74],"efficacy":[76,232],"otherwise-protective":[78],"vaccines.":[79],"Here":[80],"we":[81],"further":[82],"explore":[83],"Inhibigen":[84,116,212,275,374,396],"mechanism":[85],"action":[87],"humans":[89],"mice":[91,339],"including":[92],"whether":[93],"checkpoint":[94],"inhibition":[95],"(CPI)":[96],"ameliorate":[98],"Inhibigen-accelerated":[99,313,369],"growth.":[101],"Methods":[102],"Human":[103],"mouse":[105,218],"screens":[107],"were":[108,119,132,151,166,171,204,403],"performed":[109],"as":[110,168,243,245],"previously":[111],"described.1":[112],"ATLAS-identified":[113,342],"stimulatory":[114],"peptide":[117],"evaluated":[120],"a":[122,216,246,270,361],"therapeutic":[123,271],"B16F10":[124,217],"melanoma":[125,219],"model":[127,220],"\u00b1":[128],"CPI.":[129],"Immune":[130],"measured":[133],"ELISPOT,":[135],"flow":[136],"cytometry,":[137],"immunohistochemistry":[139],"(IHC).":[140],"Results":[141],"In":[142,266],"GEN-009":[144],"personalized":[145],"neoantigen":[146,394,451],"vaccine":[147,230,241,272],"trial":[148],"(NCT03633110),":[149],"Inhibigens":[150,225,328,343],"observed":[152],"92%":[154],"patients":[156,332],"(N=39).":[157],"Of":[158],"total":[159],"screened,":[161],"16%":[162],"(1.8":[163],"-":[164,182],"47.5%)":[165],"classified":[167],"Inhibigens,":[169],"which":[170],"found":[172],"more":[173],"often":[174],"CD4":[177],"+":[178,186,283],"(mean":[179,190],"10.3%;":[180],"0.5":[181],"42%)":[183],"versus":[184],"CD8":[185,282],"T":[187,237,250,284],"subset":[189],"6.1%;":[191],"1.2\u201323%).":[192],"No":[193],"relationship":[194],"between":[195],"Inhibigen-specific":[196],"type":[200],"mutational":[202],"burden":[203],"observed.":[205,302],"To":[206],"study":[207],"effects":[210,337],"vaccination":[213],"vivo,":[215],"was":[221,300],"employed.":[222],"Inclusion":[223],"an":[227,274],"otherwise":[228],"protective":[229],"abrogated":[231],"correlated":[234],"with":[235,309,407,422],"decreased":[236],"antigens":[242],"well":[244],"global":[247],"depression":[248],"secretion.":[253],"Early":[254],"experiments":[255],"suggest":[256,340],"these":[258],"decreases":[259],"not":[261,301],"due":[262],"MHC":[264],"competition.":[265],"addition,":[267],"administration":[268],"containing":[273],"led":[276],"reduced":[278],"infiltration":[280],"myeloid":[287],"populations.":[288],"A":[289],"corresponding":[290],"increase":[291],"classical":[293],"Tregs":[294],"periphery":[299],"Surprisingly,":[303],"preliminary":[304],"data":[305,385],"show":[306],"combination":[307],"therapy":[308],"anti-CTLA4":[310],"partially":[311],"ameliorated":[312],"but":[316],"anti-PD1":[317],"provided":[318],"no":[319,365],"additional":[320],"benefit.":[321],"Conclusions":[322],"nearly":[324],"ubiquitous":[325],"presence":[326],"human":[330],"demonstrated":[335],"pro-tumor":[336],"must":[344],"considered":[346],"omitted":[348],"design":[351],"immunotherapies.":[354],"Furthermore,":[355],"mice,":[357],"CPI":[358,378],"co-administration":[359],"has":[360],"modest":[362],"(anti-CTLA4)":[363],"(anti-PD1)":[366],"effect":[367],"on":[368],"suggesting":[372],"profiling":[375],"could":[376],"guide":[377],"selection":[379],"predict":[381],"clinical":[382],"outcome.":[383],"These":[384],"confirm":[386],"benefits":[388],"for":[393],"identification.":[397],"Ethics":[398],"Approval":[399],"All":[400],"animal":[401],"studies":[402],"undertaken":[404],"conformity":[406],"Cambridge,":[409],"MA":[410],"City":[411],"Ordinance":[412],"1086":[413],"city\u2019s":[416],"Municipal":[417],"Code":[418],"accordance":[421],"policies":[424],"protocols":[426],"approved":[427],"Genocea\u2019s":[429],"Institutional":[430],"Animal":[431],"Care":[432],"Use":[434],"Committee":[435],"(IACUC).":[436],"Reference":[437],"Nogueira":[438],"C,":[439],"Kaufmann":[440],"JK,":[441],"Lam":[442],"H,":[443],"Flechtner":[444],"JB.":[445],"Improving":[446],"through":[449],"empirical":[450],"selection.":[452],"Trends":[453],"Cancer":[455],"2018":[456],"Feb;4(2):97\u2013100":[457]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2020-11-23T00:00:00"}